1.
Sadikova N.G, Najmutdinova D. K, Urunbayeva D. A, Alimova S. E, Tillaboyev Sh.Sh. Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). Gen. Rep. [Internet]. 2023 Nov. 6 [cited 2025 Jul. 6];26:1-4. Available from: http://geniusrepo.net/index.php/1/article/view/277